CONCEPT TO MEDICINE
Live / Registered — Registered (as of 16 Jun 2026)
What this means for you
Registered since 16 Jun 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 16 Jun 2032: the §8 declaration of use).
Record
- Serial number
- 97488994
- Registration number
- 8305493
- Mark type
- Word mark
- Filed
- 05 Jul 2022
- Published for opposition
- 30 May 2023
- Registered
- 16 Jun 2026
- Next maintenance filing
- §8 declaration of use, due by 16 Jun 2032 (grace period to 16 Dec 2032)
- Attorney of record
- Max Vern
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of viral, oncological and immune system related diseases and disorders; Biological preparations for the treatment of cancer; Biological preparations for the treatment of immune system related diseases and disorders
Owner
- Concept to Medicine Biotech Co., Ltd., Pudong, Shanghai, CN
- Concept to Medicine Biotech Co., Ltd., Pudong, Shanghai, CN
- Concept to Medicine Biotech Co., Ltd., Pudong, Shanghai, CN
Prosecution history
- 16 Jun 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 16 Jun 2026 — REGISTERED-PRINCIPAL REGISTER
- 27 May 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 27 May 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 25 May 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Jan 2026 — USE AMENDMENT FILED
- 25 May 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 22 Jan 2026 — TEAS STATEMENT OF USE RECEIVED
- 22 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 23 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Jul 2025 — SOU EXTENSION 4 GRANTED
- 22 Jul 2025 — SOU EXTENSION 4 FILED
- 22 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Jan 2025 — SOU EXTENSION 3 GRANTED